SPC2996 in Chronic Lymphocytic Leukaemia

Clinical trial NCT00285103 · COMPLETED

Trial details

NCT number: NCT00285103
Sponsor: Santaris Pharma A/S
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2005-06-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.